Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check4 days agoChange DetectedNew status-related fields and sponsor information appear in the study record history (Unknown status, Last known status was, Last verified, 2024-07, Oryzon Genomics S.A., Recruitment Status). Deletions remove Find Contact Information and Check who can join from the page.SummaryDifference0.8%

- Check11 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions history, and the previous revision v3.6.3 was removed from the list, reflecting an update to the study's version history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study record history, and the prior revision v3.6.2 was removed from the list.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study record history adds a new revision entry (v3.6.2) indicating a small update to the page, while the previous revision (v3.6.0) is removed in this change.SummaryDifference0.1%

- Check54 days agoChange DetectedIntroduces new UI items 'Check who can join' and 'Find Contact Information' in the history view and adds the release label 'Revision: v3.6.0'. The older release label 'Revision: v3.5.5' has been removed.SummaryDifference0.5%

- Check61 days agoChange DetectedA new revision entry v3.5.5 appears in the history and the previous revision v3.5.4 is removed, updating the record's revision history.SummaryDifference0.1%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.